Yahoo
NYSE - Nasdaq Real Time Price USD

UnitedHealth Group Incorporated (UNH)

409.92 -0.99 (-0.24%)
As of 2:00:11 PM EDT. Market Open.
Trade UNH on Coinbase
Chart Range Bar
Loading chart for UNH

What's happening with UNH?

15m ago
Powered by Yahoo Scout

UnitedHealth’s third-quarter recovery is gaining traction, supported by stronger Medicare Advantage margins, higher Optum Health earnings, and raised 2026 adjusted earnings guidance. Commercial medical costs, Medicaid membership losses, regulatory changes, and a still-depressed operating margin remain the central risks.

Powered by Yahoo Scout
  • Previous Close 410.91
  • Open 415.00
  • Bid 408.93 x 4000
  • Ask 409.16 x 24000
  • Day's Range 406.04 - 416.11
  • 52 Week Range 255.97 - 461.62
  • Volume 2,020,044
  • Avg. Volume 5,024,570
  • Market Cap (intraday) 367.939B
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) 23.40
  • EPS (TTM) 17.52
  • Earnings Date Jan 12, 2027
  • Forward Dividend & Yield 9.28 (2.26%)
  • 1y Target Est 476.64
  • Morningstar Rating Rating available with Stock Picks access

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.

www.unitedhealthgroup.com

390,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

UNH
26.63%
S&P 500 (^GSPC)
10.46%

1-Year Return

UNH
22.07%
S&P 500 (^GSPC)
10.84%

3-Year Return

UNH
17.64%
S&P 500 (^GSPC)
81.48%

5-Year Return

UNH
2.56%
S&P 500 (^GSPC)
64.19%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 112.69B
Earnings 4.11B
Profit Margin 3.65%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
20B
40B
60B
80B
100B
1.0%
2.0%
3.0%
4.0%
5.0%

Analyst Insights

View More

Analyst Price Targets

380.00 Low
476.64 Average
409.92 Current
531.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/27/2026
Analyst Wells Fargo
Rating Action Maintains
Rating Overweight
Price Action Lowers
Price Target 526 -> 487

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.53%

  • Return on Assets (ttm)

    5.24%

  • Return on Equity (ttm)

    15.77%

  • Revenue (ttm)

    450.06B

  • Net Income Avi to Common (ttm)

    15.88B

  • Diluted EPS (ttm)

    17.52

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.55B

  • Total Debt/Equity (mrq)

    70.43%

  • Levered Free Cash Flow (ttm)

    26.5B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: